RaySearch Laboratories is recalling certain versions of its RayCare oncology information system software, including versions 5A, 5B, and 6A, due to a software defect that prevents medication allergy warnings from appearing. This oncology information system is used in clinical settings to manage patient treatment plans and scheduling. One installation is affected by this recall, which was initiated after it was discovered that clinicians may not be notified of a patient's drug allergies during the planning or treatment process. Consumers and healthcare providers should contact the manufacturer or their healthcare facility's IT department to ensure the software has been updated.
The software may fail to display critical allergy warnings for specific medication substances or drug ingredients. If a clinician is unaware of a patient's allergy because the warning did not appear, they may inadvertently prescribe or administer a medication that causes a serious allergic reaction.
Software update/Service pack
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.